<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01234701</url>
  </required_header>
  <id_info>
    <org_study_id>MRI_Liver_Tumours_Evlauation</org_study_id>
    <nct_id>NCT01234701</nct_id>
  </id_info>
  <brief_title>Agreement Among Expert Radiologists in Diagnosing Primary Liver Tumors by Magnetic Resonance Imaging (MRI)</brief_title>
  <acronym>MRevaluation</acronym>
  <official_title>Agreement Among Expert Radiologists in Diagnosing Primary Liver Tumors by Magnetic Resonance Imaging (MRI) in Non-Cirrhotic Patients - A Double Blind International Multicenter Study</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>University of Zurich</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Harvard University</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>University Hospital, Essen</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Auckland City Hospital</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>University Hospital, Strasbourg, France</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>The Leeds Teaching Hospitals NHS Trust</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Imperial College London</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>University College London Hospitals</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>St. Louis University</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>University of Zurich</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The purpose of this multicenter study is to evaluate the agreement among expert radiologists
      in interpreting magnetic resonance images (MRI) assessing common primary liver tumours in
      non-cirrhotic patients.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Magnetic Resonance Imaging (MRI) is currently the method of choice for non-invasive diagnosis
      of primary liver tumors. However, differentiation of hepatocellular carcinoma (HCC) from
      adenoma and focal nodular hyperplasia (FNH) remains challenging, particularly in
      non-cirrhotic patients.
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date>October 2010</start_date>
  <completion_date type="Actual">May 2012</completion_date>
  <primary_completion_date type="Actual">May 2012</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Cohort</observational_model>
    <time_perspective>Retrospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>Inter-observer agreement among expert radiologists in diagnosing primary liver tumors by Magnetic Resonance Imaging (MRI).</measure>
    <time_frame>December 2010</time_frame>
    <description>Inter-observer agreement for categorical data will by assessed by the Fliess' kappa (good agreement &gt;0.7).</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Agreement of radiologists with the actual diagnosis of primary liver tumors assessed by Magnetic Resonance Imaging (MRI).</measure>
    <time_frame>December 2010</time_frame>
    <description>The actual diagnosis is defined as the histopathology diagnosis of the resected liver specimen, the current gold standard technique. Such agreement will be assessed by Cohen's Kappa (good agreement &gt;0.7).</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Differences in radiologist' certainty of diagnosis (CoD) among different tumor types.</measure>
    <time_frame>December 2010</time_frame>
    <description>Radiologist' certainty of diagnosis (CoD) will be assessed by a Visual Analogue Scale (VAS 1-10). Potential differences in CoD will be identified by non-parametric multiple comparisons.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Intra-class correlation coefficient among radiologists' Certainty of Diagnosis (CoD) in diagnosis primary liver tumors by Magnetic Resonant Imaging (MRI)</measure>
    <time_frame>December 2010</time_frame>
    <description>Intra-class correlation coefficient is a descriptive statistic that can be used when quantitative measurements are made on units that are organized into groups. It describes how strongly units in the same group resemble each other.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Investigate the diagnostic efficacy of radiologists' certainty of diagnosis (CoD) in accurately predicting primary liver tumors assessed by Magnetic Resonant Imaging (MRI)</measure>
    <time_frame>December 2010</time_frame>
    <description>Diagnostic efficacy will be assessed by Receiver Operating Characteristic (ROC) Curves.</description>
  </secondary_outcome>
  <number_of_groups>1</number_of_groups>
  <enrollment type="Actual">108</enrollment>
  <condition>Neoplasms</condition>
  <arm_group>
    <arm_group_label>Primary liver tumors, non-cirrhotic</arm_group_label>
    <description>This single Cohort/Group will include all consecutive patients that received pre-operative Magnetic Resonance Imaging (MRI) and underwent resection for primary liver tumors.</description>
  </arm_group>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Non-invasive Magnetic Resonance Imaging (MRI)</intervention_name>
    <description>Conventional pre-operative MRI</description>
    <arm_group_label>Primary liver tumors, non-cirrhotic</arm_group_label>
    <other_name>Magnetic Resonance Imaging</other_name>
  </intervention>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>Liver resection</intervention_name>
    <description>Hepatectomy with an intention to cure</description>
    <arm_group_label>Primary liver tumors, non-cirrhotic</arm_group_label>
    <other_name>Hepatectomy = liver resection by open surgery.</other_name>
  </intervention>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Histopathology diagnosis of resected liver specimen</intervention_name>
    <description>Histopathology diagnosis by expert pathologist.</description>
    <arm_group_label>Primary liver tumors, non-cirrhotic</arm_group_label>
    <other_name>Examination under the microscope.</other_name>
  </intervention>
  <eligibility>
    <study_pop>
      <textblock>
        Primary care clinics
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Histopathological diagnosis of Hepatocellular Cancer (HCC), Adenoma and/or Focular
             nodular hyperplasia (FNH).

          -  Patients that received a pre-operative Magnetic Resonance Imaging (MRI).

          -  Patients that underwent liver resection with an intention to cure.

          -  Patient over 18 years of age

        Exclusion Criteria:

          -  Other histopathological diagnosis such as cysts and hemangiomas.

          -  Patient age less than 18 years of age.
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>90 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Stefan Breitenstein, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>University Hospital Zurich, Department of Visceral and Transplant Surgery, Zurich, Switzerland</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Harvard Medical School, Massachusetts General Hospital, and Beth Israel Deaconess Medical Center</name>
      <address>
        <city>Boston</city>
        <state>Massachusetts</state>
        <zip>02117-0825</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>St. Louis University, Liver Center</name>
      <address>
        <city>Saint Louis</city>
        <state>Missouri</state>
        <zip>63110-0250</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>University Hospital Strasbourg</name>
      <address>
        <city>Strasbourg</city>
        <state>Cedex</state>
        <zip>67098</zip>
        <country>France</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>University Hospital Essen</name>
      <address>
        <city>Essen</city>
        <zip>45147</zip>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Auckland City Hospital</name>
      <address>
        <city>Auckland</city>
        <zip>9</zip>
        <country>New Zealand</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>University Hospital Zurich, Department of Interventional and Diagnostic Radiology</name>
      <address>
        <city>Zurich</city>
        <zip>8091</zip>
        <country>Switzerland</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>University Hospital Zurich, Department of Visceral and Transplant Surgery, Swiss Hepato-Pancreato-Biliary (HPB) Center</name>
      <address>
        <city>Zurich</city>
        <zip>8091</zip>
        <country>Switzerland</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>The Leeds Teaching Hospitals NHS Trust</name>
      <address>
        <city>Leeds</city>
        <zip>LS9 7TF</zip>
        <country>United Kingdom</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>University College London Hospitals NHS Foundation Trust</name>
      <address>
        <city>London</city>
        <zip>NW1 2PG</zip>
        <country>United Kingdom</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Imperial College, Hammersmith Hospital</name>
      <address>
        <city>London</city>
        <zip>W12 0HS</zip>
        <country>United Kingdom</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>France</country>
    <country>Germany</country>
    <country>New Zealand</country>
    <country>Switzerland</country>
    <country>United Kingdom</country>
    <country>United States</country>
  </location_countries>
  <link>
    <url>http://en.wikipedia.org/wiki/Inter-rater_reliability</url>
    <description>Inter-rater reliability (also called: inter-rater agreement, or concordance) definitions and further information</description>
  </link>
  <link>
    <url>http://en.wikipedia.org/wiki/Fleiss%27_kappa</url>
    <description>Fleiss' kappa information</description>
  </link>
  <link>
    <url>http://en.wikipedia.org/wiki/Cohen%27s_kappa</url>
    <description>Cohen's kappa information</description>
  </link>
  <link>
    <url>http://en.wikipedia.org/wiki/Intra-class_correlation_coefficient</url>
    <description>Intraclass correlation information</description>
  </link>
  <verification_date>May 2012</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>November 3, 2010</study_first_submitted>
  <study_first_submitted_qc>November 3, 2010</study_first_submitted_qc>
  <study_first_posted type="Estimate">November 4, 2010</study_first_posted>
  <last_update_submitted>May 25, 2012</last_update_submitted>
  <last_update_submitted_qc>May 25, 2012</last_update_submitted_qc>
  <last_update_posted type="Estimate">May 28, 2012</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>Liver</keyword>
  <keyword>Neoplasms</keyword>
  <keyword>Magnetic Resonance Imaging</keyword>
  <keyword>Surgery</keyword>
  <keyword>Pathology</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Liver Neoplasms</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Liver Extracts</mesh_term>
  </intervention_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

